BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
November 01, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
October 31, 2023 08:57 ET
|
Stereotaxis, Inc.
Stereotaxis (NYSE: STXS) & Abbott (NYSE:ABT) announce the first patients in the US have been treated successfully utilizing combined technologies
Global Cardiac Ablation Device Market Set for Remarkable Growth, Fueled by Rising Demand for Minimally Invasive Procedures and Technological Advancements
October 30, 2023 08:13 ET
|
Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Cardiac Ablation Devices Market" report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the...
Implantable Defibrillators Global Market Research Report 2023: Growth Fueled by Rising Sudden Cardiac Arrest Cases - Long-term Forecast to 2027 and 2032
October 24, 2023 05:10 ET
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Implantable Defibrillators Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global implanted defibrillator...
The Rise of Pulsed Field Ablation: A Safer, Minimally Invasive Solution for Atrial Fibrillation and Cardiac Arrhythmias
October 18, 2023 06:28 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share...
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
October 04, 2023 08:49 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Electrophysiology Ablation Market Grows Strong, Aiming for US$ 7.9 Billion by 2033 | Persistence Market Research
September 28, 2023 06:03 ET
|
Persistence Market Research
New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The electrophysiological ablation market is expected to generate US$ 3.1 billion in revenue globally in 2022 and grow at a CAGR of 8.8% to US$ 7.9...
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
September 06, 2023 08:56 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
August 24, 2023 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
August 23, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 23, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...